Weill Cornell Medicine names new chief of pediatric cardiology

Pediatric cardiologist Ralf Holzer, MD, has been named chief of the pediatric cardiology department at New York-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine, as well as director for the Pediatric Cardiac Catheterization at the Komansky Children’s Hospital.

He assumed his new duties at the New York-based provider on June 1, but has been part of the Weill Cornell team as a professor of clinical pediatrics since 2016, according to a press release from the provider.

“Dr. Holzer is a renowned expert who is committed to innovative interventional techniques and approaches to pediatric cardiology care,” said Gerald Loughlin, MD, the Nancy C. Paduano professor and chairman of the Department of Pediatrics at Weill Cornell Medicine, and pediatrician-in-chief of the Komansky Children’s Hospital, in a statement. “He is adept at even the most challenging pediatric cardiology cases, and brings a tremendous amount of proven skill, experience and talent that will enhance the already exceptional care we are known for. Patients with congenital heart disease and cardiac conditions are in the best possible hands under Dr. Holzer’s leadership."

In his new position, Holzer said he plans to closely collaborate with other pediatric cardiology programs across the region in an effort to improve quality and efficiency. At his practice, he will provide cardiac catheterization services to treat congenital heart disease and birth defects.

Holzer earned his medical degree from the Johannes Gutenberg University of Mainz in Germany, and completed his cardiology fellowship at the Royal Liverpool Children’s Hospital in the United Kingdom.

He has more than 80 articles published in journals, such as Pediatrics, Circulation and JACC.

“Quality of care, patient satisfaction and helping our patients achieve positive outcomes is at the core of our clinical work,” Holzer said. “I look forward to working with this team, which has already received national recognition for its treatment of congenital heart disease, to deliver the highest quality care to patients and their families.”